However, although the main neuropathological feature in ChAc patients is the selective degeneration of the caudate nucleus and putamen, the concentration of VPS13A in basal ganglia nuclei is weak (Kurano et al., 2007; García-García et al., 2021). This evidence concerns the gene VPS13A and chorea-acanthocytosis.